132 related articles for article (PubMed ID: 15072701)
1. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable?
Blakesley V; Awni W; Locke C; Ludden T; Granneman GR; Braverman LE
Thyroid; 2004 Mar; 14(3):191-200. PubMed ID: 15072701
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
3. Current methodology to assess bioequivalence of levothyroxine sodium products is inadequate.
Blakesley VA
AAPS J; 2005 Mar; 7(1):E42-6. PubMed ID: 16146348
[TBL] [Abstract][Full Text] [Related]
4. New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.
Green WL
AAPS J; 2005 Mar; 7(1):E54-8. PubMed ID: 16146330
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence studies for levothyroxine.
Bolton S
AAPS J; 2005 Mar; 7(1):E47-53. PubMed ID: 16146349
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
[TBL] [Abstract][Full Text] [Related]
7. Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.
Benvenga S; Carlé A
Adv Ther; 2019 Sep; 36(Suppl 2):59-71. PubMed ID: 31485974
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.
Colucci P; D'Angelo P; Mautone G; Scarsi C; Ducharme MP
Ther Drug Monit; 2011 Jun; 33(3):355-61. PubMed ID: 21516059
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of levothyroxine tablets administered to a target population in steady state.
Cerutti R; Rivolta G; Cavalieri L; Di Giulio C; Grossi E; Vago T; Baldi G; Righini V; Marzo A
Pharmacol Res; 1999 Mar; 39(3):193-201. PubMed ID: 10094844
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of levothyroxine tablets compared to reference tablets and an oral solution.
Koytchev R; Lauschner R
Arzneimittelforschung; 2004; 54(10):680-4. PubMed ID: 15553108
[TBL] [Abstract][Full Text] [Related]
11. L-T4 bioequivalence and hormone replacement studies via feedback control simulations.
Eisenberg M; Samuels M; DiStefano JJ
Thyroid; 2006 Dec; 16(12):1279-92. PubMed ID: 17199439
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and pharmacokinetics of levothyroxine suppository in patients with hypothyroidism.
Kashiwagura Y; Uchida S; Tanaka S; Watanabe H; Masuzawa M; Sasaki T; Namiki N
Biol Pharm Bull; 2014; 37(4):666-70. PubMed ID: 24694613
[TBL] [Abstract][Full Text] [Related]
13. A study in normal human volunteers to compare the rate and extent of levothyroxine absorption from Synthroid and Levoxine.
Berg JA; Mayor GH
J Clin Pharmacol; 1992 Dec; 32(12):1135-40. PubMed ID: 1487553
[TBL] [Abstract][Full Text] [Related]
14. Limitations of Levothyroxine Bioequivalence Evaluation: Analysis of An Attempted Study.
Mayor GH; Orlando T; Kurtz NM
Am J Ther; 1995 Jun; 2(6):417-432. PubMed ID: 11850687
[TBL] [Abstract][Full Text] [Related]
15. Thyroxine and treatment of hypothyroidism: seven decades of experience.
Mateo RCI; Hennessey JV
Endocrine; 2019 Oct; 66(1):10-17. PubMed ID: 31321670
[TBL] [Abstract][Full Text] [Related]
16. New Formulations of Levothyroxine in the Treatment of Hypothyroidism: Trick or Treat?
Nagy EV; Perros P; Papini E; Katko M; Hegedüs L
Thyroid; 2021 Feb; 31(2):193-201. PubMed ID: 33003978
[No Abstract] [Full Text] [Related]
17. Levothyroxine dosage and the limitations of current bioequivalence standards.
Hennessey JV
Nat Clin Pract Endocrinol Metab; 2006 Sep; 2(9):474-5. PubMed ID: 16957756
[No Abstract] [Full Text] [Related]
18. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine: therapeutic use and regulatory issues related to bioequivalence.
Wartofsky L
Expert Opin Pharmacother; 2002 Jun; 3(6):727-32. PubMed ID: 12036412
[TBL] [Abstract][Full Text] [Related]
20. Metformin Does Not Suppress Serum Thyrotropin by Increasing Levothyroxine Absorption.
Al-Alusi MA; Du L; Li N; Yeh MW; He X; Braverman LE; Leung AM
Thyroid; 2015 Oct; 25(10):1080-4. PubMed ID: 26191653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
